Literature DB >> 10671353

Trovafloxacin-induced acute hepatitis.

M I Lucena1, R J Andrade, L Rodrigo, J Salmerón, A Alvarez, M J Lopez-Garrido, R Camargo, R Alcantára.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671353     DOI: 10.1086/313680

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

2.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

3.  Cell biology: The disassembly of death.

Authors:  Christopher D Gregory
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

Review 4.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.

Authors:  Raúl-J Andrade; Mercedes Robles; Alejandra Fernández-Castañer; Susana López-Ortega; M-Carmen López-Vega; M-Isabel Lucena
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 6.  Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors:  Françoise Van Bambeke; Paul M Tulkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis.

Authors:  Einat Gorelik; Reem Masarwa; Amichai Perlman; Victoria Rotshild; Momen Abbasi; Mordechai Muszkat; Ilan Matok
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

Review 8.  Hypersensitivity reactions to fluoroquinolones.

Authors:  Kathrin Scherer; Andreas J Bircher
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

Review 9.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

Review 10.  Chemical Aspects of Human and Environmental Overload with Fluorine.

Authors:  Jianlin Han; Loránd Kiss; Haibo Mei; Attila Márió Remete; Maja Ponikvar-Svet; Daniel Mark Sedgwick; Raquel Roman; Santos Fustero; Hiroki Moriwaki; Vadim A Soloshonok
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.